Publicado: quinta-feira, 1 de Outubro de 2009 21:30
Autor: Ronald F. van Vollenhoven
Few, if any, areas of medical therapeutics have witnessed such dramatic changes as those that have occurred in the therapy of rheumatoid arthritis (RA) during the past two decades. Improvements in clinical trials methodologies, the introduction of no fewer than nine biologic agents with distinct